• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苯甲酰胺在体外和体内增强博来霉素的抗肿瘤活性。

Enhancement of antitumor activity of bleomycin by benzamide in vitro and in vivo.

作者信息

Sakamoto H, Kawamitsu H, Miwa M, Terada M, Sugimura T

出版信息

J Antibiot (Tokyo). 1983 Mar;36(3):296-300. doi: 10.7164/antibiotics.36.296.

DOI:10.7164/antibiotics.36.296
PMID:6187722
Abstract

The cytotoxic effects of bleomycin on HeLa cells in culture were enhanced by incubation of the cells with benzamide, a potent inhibitor of poly(ADP-ribose) polymerase, at concentrations at which benzamide alone did not show any cytotoxicity. Benzamide plus bleomycin display enhanced therapeutic effects against Ehrlich ascites tumor cells in vivo. On daily treatment with various doses of bleomycin plus benzamide for 10 days, mice with Ehrlich ascites tumors survived longer than mice on treatment with bleomycin alone.

摘要

在培养的HeLa细胞中,博来霉素的细胞毒性作用通过将细胞与聚(ADP - 核糖)聚合酶的有效抑制剂苯甲酰胺一起孵育而增强,苯甲酰胺单独使用时在该浓度下未显示任何细胞毒性。苯甲酰胺加博来霉素在体内对艾氏腹水肿瘤细胞显示出增强的治疗效果。在用不同剂量的博来霉素加苯甲酰胺每日治疗10天的情况下,患有艾氏腹水肿瘤的小鼠比单独用博来霉素治疗的小鼠存活时间更长。

相似文献

1
Enhancement of antitumor activity of bleomycin by benzamide in vitro and in vivo.苯甲酰胺在体外和体内增强博来霉素的抗肿瘤活性。
J Antibiot (Tokyo). 1983 Mar;36(3):296-300. doi: 10.7164/antibiotics.36.296.
2
Enhancement of bleomycin activity by 3-aminobenzamide, a poly (ADP-ribose) synthesis inhibitor, in vitro and in vivo.
Anticancer Res. 1988 Mar-Apr;8(2):239-43.
3
Inhibitors of poly(adenosine diphosphate ribose) polymerase potentiate the antitumor activity of bleomycin against Ehrlich ascites carcinoma.聚(腺苷二磷酸核糖)聚合酶抑制剂可增强博来霉素对艾氏腹水癌的抗肿瘤活性。
J Pharmacobiodyn. 1982 Nov;5(11):900-4. doi: 10.1248/bpb1978.5.900.
4
The antitumor effect of bleomycin combined with bestatin against Ehrlich ascites carcinoma in mice.
Proc Soc Exp Biol Med. 1988 Mar;187(3):292-5. doi: 10.3181/00379727-187-42667.
5
[Enhancement of bleomycin or hyperthermia induced tumor cell damage by ADPRT inhibitor].
Zhonghua Zhong Liu Za Zhi. 1992 Nov;13(6):423-6.
6
Effects of alkylating antineoplastics alone or in combination with 3-aminobenzamide on genotoxicity, antitumor activity, and NAD levels in human lymphocytes in vitro and on Ehrlich ascites tumor cells in vivo.烷化抗肿瘤药单独或与3-氨基苯甲酰胺联合应用对体外培养的人淋巴细胞以及体内艾氏腹水瘤细胞的遗传毒性、抗肿瘤活性和NAD水平的影响。
Teratog Carcinog Mutagen. 1990;10(4):321-31. doi: 10.1002/tcm.1770100405.
7
[Enhancement of antitumor activity of bleomycin A5 in mouse sarcoma 180 cells in vitro and in vivo by verapamil].
Zhongguo Yao Li Xue Bao. 1990 Jul;11(4):381-4.
8
Potentiation of the cytotoxicity of peplomycin against Ehrlich ascites carcinoma by bleomycin hydrolase inhibitors.博来霉素水解酶抑制剂增强培普利欧霉素对艾氏腹水癌的细胞毒性作用。
J Antibiot (Tokyo). 1987 Dec;40(12):1794-5. doi: 10.7164/antibiotics.40.1794.
9
Pimaricin potentiation of bleomycin activity against murine tumors.匹马菌素增强博来霉素对小鼠肿瘤的活性。
Gan. 1983 Aug;74(4):602-6.
10
Cytostatic and cytotoxic response of Ehrlich ascites tumor cells in vivo on chronic treatment with cytarabine, bleomycin, and peplomycin.阿糖胞苷、博来霉素和培普利霉素对艾氏腹水瘤细胞体内长期治疗的细胞生长抑制和细胞毒性反应。
Arzneimittelforschung. 1984;34(4):451-4.

引用本文的文献

1
Poly(ADP-Ribose) Glycohydrolase (PARG) vs. Poly(ADP-Ribose) Polymerase (PARP) - Function in Genome Maintenance and Relevance of Inhibitors for Anti-cancer Therapy.聚(ADP-核糖)糖水解酶(PARG)与聚(ADP-核糖)聚合酶(PARP)——在基因组维持中的功能以及抑制剂在抗癌治疗中的相关性
Front Mol Biosci. 2020 Aug 28;7:191. doi: 10.3389/fmolb.2020.00191. eCollection 2020.
2
Enhancement of cyclophosphamide cytotoxicity in vivo by the benzamide analogue pyrazinamide.苯甲酰胺类似物吡嗪酰胺增强环磷酰胺在体内的细胞毒性。
Br J Cancer. 1994 Apr;69(4):648-54. doi: 10.1038/bjc.1994.126.
3
Modulation of nicotinamide adenine dinucleotide and poly(adenosine diphosphoribose) metabolism by the synthetic "C" nucleoside analogs, tiazofurin and selenazofurin. A new strategy for cancer chemotherapy.
合成的“C”核苷类似物替拉扎明和硒代替拉扎明对烟酰胺腺嘌呤二核苷酸和聚(腺苷二磷酸核糖)代谢的调节作用。一种癌症化疗的新策略。
J Clin Invest. 1985 Feb;75(2):702-9. doi: 10.1172/JCI111750.
4
Changes in the response of the RIF-1 tumour to melphalan in vivo induced by inhibitors of nuclear ADP-ribosyl transferase.核ADP-核糖基转移酶抑制剂诱导的RIF-1肿瘤对美法仑体内反应的变化。
Br J Cancer. 1986 Feb;53(2):247-54. doi: 10.1038/bjc.1986.42.
5
High induction of poly(ADP-ribose) polymerase activity in bleomycin-resistant HeLa cells.博来霉素耐药的HeLa细胞中多聚(ADP-核糖)聚合酶活性的高诱导。
Jpn J Cancer Res. 1989 May;80(5):464-8. doi: 10.1111/j.1349-7006.1989.tb02337.x.
6
Participation of poly(ADP-ribose) polymerase in the drug sensitivity in human lung cancer cell lines.聚(ADP - 核糖)聚合酶在人肺癌细胞系药物敏感性中的作用。
J Cancer Res Clin Oncol. 1992;118(4):244-8. doi: 10.1007/BF01208612.